SEC Form 4 · accession 0001179110-19-003473
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Visioli
Officer — Chief Financial Officer
Period of report
Mar 4, 2019
Accepted (ET)
Mar 6, 2019 · 6:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 4, 2019 | F | 78 | $25.53 | D | 8,083 | D | |
| Common StockF2 | Mar 4, 2019 | F | 212 | $25.53 | D | 7,871 | D | |
| Common StockF3 | Mar 4, 2019 | F | 238 | $25.53 | D | 7,633 | D | |
| Common StockF4 | Mar 4, 2019 | F | 381 | $25.53 | D | 7,252 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares of common stock were withheld for payment of taxes in connection with the vesting of 208 shares of restricted stock from previously reported grant.
- F2Shares of common stock were withheld for payment of taxes in connection with the vesting of 567 shares of restricted stock from previously reported grant.
- F3Shares of common stock were withheld for payment of taxes in connection with the vesting of 641 shares of restricted stock from previously reported grant.
- F4Shares of common stock were withheld for payment of taxes in connection with the vesting of 1,042 shares of restricted stock from previously reported grant.